IPO Plus

₹1,588.9

▼ -24.52 -1.52%

06 Aug 2026

NSE Listed · Pharmaceuticals

Aurobindo Pharma Ltd. (AUROPHARMA)

Volume: 12,99,019Avg Vol 1W: 13,72,843Avg Vol 1M: 9,59,55652W Range:₹1,016.1₹1,636.8
NSE BSE www.aurobindo.com AI Report
Key Ratios
Checked just now
Market Cap₹92,284 Cr
Current Price₹1,588.9
Previous Close₹1,613.42
High / Low (52w)₹1,636.8 / ₹1,016.1
Volume12,99,019
Avg Vol (1W)13,72,843
Avg Vol (1M)9,59,556
Stock P/E100.18
Book Value₹652.39
Dividend Yield0.27%
ROE9.25%
ROA5.99%
Revenue (TTM)—
Revenue Growth9.39%
Profit Margin10.5%
Total Debt₹1,559 Cr
Shares Outstanding58 Cr
Face Value₹1
EPS (TTM)₹15.86
P/B2.44
Debt / Equity0.21
50 DMA₹1,521.24
200 DMA₹1,321.03
Day change-1.52%
Price Chart
₹1,588.9▲ 48.18% · 1Y
₹1621₹102285.8L
2025-08-06
2026-08-06

20-day avg volume: 9.6L shares

Pros
  • Company is almost debt-free.
  • Revenue grew 1125% YoY.
  • Net profit is growing year over year.
Cons
  • Stock trades at a high P/E of 100.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹7,567 Cr₹7,796 Cr₹7,979 Cr₹8,382 Cr₹7,868 Cr₹8,286 Cr₹8,646 Cr₹8,853 Cr
EBITDA₹1,436 Cr₹1,320 Cr₹1,317 Cr₹1,482 Cr₹1,303 Cr₹1,370 Cr₹1,496 Cr₹1,391 Cr
Net Profit₹919 Cr₹817 Cr₹846 Cr₹903 Cr₹825 Cr₹848 Cr₹910 Cr₹921 Cr
EPS————————
Profit & Loss (Annual)
MetricDec 2024Mar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Mar 2026
Revenue₹2,917 Cr₹32,346 Cr₹2,732 Cr₹2,848 Cr₹2,790 Cr₹2,747 Cr₹34,145 Cr₹2,787 Cr
EBITDA₹699 Cr₹5,555 Cr₹617 Cr₹810 Cr₹813 Cr₹848 Cr₹5,560 Cr₹924 Cr
Net Profit₹472 Cr₹3,486 Cr₹408 Cr₹559 Cr₹581 Cr₹582 Cr₹3,505 Cr₹692 Cr
EPS—59.81————60.34—
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹26,454 Cr₹28,928 Cr₹33,854 Cr₹33,922 Cr₹39,890 Cr₹45,072 Cr₹49,785 Cr₹58,502 Cr
Total Liabilities₹12,562 Cr₹12,103 Cr₹11,925 Cr₹9,348 Cr₹13,038 Cr₹15,221 Cr₹17,138 Cr₹20,619 Cr
Equity₹13,892 Cr₹16,825 Cr₹21,929 Cr₹24,574 Cr₹26,852 Cr₹29,851 Cr₹32,647 Cr₹37,883 Cr
Total Debt————————
Cash Flow
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹2,421 Cr₹5,142 Cr₹4,614 Cr₹6,275 Cr₹3,104 Cr₹4,201 Cr₹5,656 Cr₹7,358 Cr
Investing₹-2,903 Cr₹-1,568 Cr₹599 Cr₹-3,212 Cr₹-3,978 Cr₹-4,256 Cr₹-1,876 Cr₹-3,459 Cr
Financing₹1,919 Cr₹-1,947 Cr₹-1,365 Cr₹-2,969 Cr₹1,814 Cr₹800 Cr₹120 Cr₹-1,269 Cr
Free Cash Flow₹2,421 Cr₹5,142 Cr₹4,614 Cr₹6,275 Cr₹3,104 Cr₹4,201 Cr₹5,656 Cr₹7,358 Cr
Shareholding
Promoter 51.88% Institutions 41.48% Public 6.64%
Efficiency & Working Capital
ROCE10.8%
Interest Coverage12.1
Dividend Payout—
Debtor Days77 d
Inventory Days131 d
Payable Days60 d
Cash Conversion Cycle147 d
Working Capital Days208 d
Shareholding Details

As of 2026-06-30

Promoter51.9%
FII16.4%
DII25.1%
Institutions41.5%
Public6.6%
Promoter Pledge13.8%
No. of Shareholders2,39,073
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters51.8%51.8%51.8%51.8%51.8%51.8%51.8%51.8%51.8%51.8%51.8%51.9%
FIIs22.5%20.7%18%16.7%16.6%16.3%15.3%14.4%14.2%13.9%15.2%16.4%
DIIs17.9%20.2%23.3%24.8%25.1%25.2%26.2%26.9%27.6%27.7%25.9%25.1%
Public7.8%7.2%6.9%6.7%6.5%6.7%6.6%6.9%6.4%6.6%7.1%6.6%
Promoter Pledge19.6%18.9%20.9%20.9%20.4%17.8%16.9%17.1%17.5%17.5%23.7%13.8%
No. of Shareholders2,59,6382,41,9442,44,5752,38,6222,48,4882,57,9622,69,3232,72,2082,47,6622,36,8592,41,2982,39,073
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Rpr Sons Advisors Private Limited, Mrs.p.suneela Rani (jointly Holding)Shareholding of Promoter and Promoter Group33.5%19.30 Cr
Quant Mutual FundPublic Shareholding5%2.85 Cr
Kambam Nithyananda ReddyShareholding of Promoter and Promoter Group4.4%2.51 Cr
Sbi Large & Midcap FundPublic Shareholding3.6%2.05 Cr
Kirthi Reddy KambamShareholding of Promoter and Promoter Group3.5%1.99 Cr
Hdfc Mutual FundPublic Shareholding3.2%1.85 Cr
Venkata Ramprasad Reddy PenakaShareholding of Promoter and Promoter Group3.1%1.77 Cr
Life Insurance Corporation Of IndiaPublic Shareholding2.9%1.69 Cr
Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.ltd. (jointly Holding)Shareholding of Promoter and Promoter Group2.9%1.64 Cr
Nps Trust - A/c Sbi Pension Fund Scheme - Nps TierPublic Shareholding2.7%1.58 Cr
M SivakumaranShareholding of Promoter and Promoter Group2.5%1.42 Cr
Kambam SpoorthiShareholding of Promoter and Promoter Group1.2%68,83,414
Kottamanchi RajeswariShareholding of Promoter and Promoter Group0.3%17,94,100
M Sumanth Kumar ReddyShareholding of Promoter and Promoter Group0.3%15,72,477
Trident Chemphar LimitedShareholding of Promoter and Promoter Group0.1%7,75,957
Axis Clinicals LimitedShareholding of Promoter and Promoter Group0.1%6,46,682
Prasada Reddy KambhamShareholding of Promoter and Promoter Group0.1%2,95,976
Suneela Rani PenakaShareholding of Promoter and Promoter Group0%1,27,765
Kambam Surya Prakash ReddyShareholding of Promoter and Promoter Group0%7,380
Penaka Neha ReddyShareholding of Promoter and Promoter Group0%0
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Kottamanchi Rajeswari2,00,00011.2%2026-06-30
Kambam Nithyananda Reddy96,50,00038.4%2026-06-30
Prasada Reddy Kambham1,00,00033.8%2026-06-30
M Sumanth Kumar Reddy8,00,00050.9%2026-06-30
Kirthi Reddy Kambam27,00,00013.6%2026-06-30
Kambam Spoorthi4,00,0005.8%2026-06-30
Rpr Sons Advisors Private Limited, Mrs.p.suneela Rani (jointly Holding)2.72 Cr14.1%2026-06-30
Board of Directors
NameDesignationYear
Kambam Nityananda ReddyVice Chairman & Managing Director2025
M Madan Mohan ReddyWhole-time Director2025
P V Ramprasad ReddyNon Executive Director2025
Girish Paman VanvariIndependent Director2025
P Sarath Chandra ReddyNon Executive Director2025
Santanu MukherjeeIndependent Director2025
M R KumarChairman & Independent Director2025
Satakarni MakkapatiNon Executive Director2025
B Adi ReddyCompany Sec. & Compli. Officer2025
Punita Kumar SinhaAdditional Director2025
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹14545858
Corporate Actions
TypeDateValueRemark
forthcoming2026-08-05Board Meetings—
buyback2026-04-29₹1475 max—
dividend2025-08-08₹4 (400%)Interim
forthcoming—Book ClosureAGM
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202518,20918512068218,979
20258,213014008,227
20252,1991833206722,942
Insider / Designated-Person Trades

30 recent disclosure(s)

RPR Sons Advisors Pvt.Ltd. Mrs.P.Suneela Rani jointly holdingRevoke · 1,16,35,862
RPR Sons Advisors Pvt.Ltd. Mrs.P.Suneela Rani jointly holdingPledge · 1,67,00,000
A.Janardhana KamathDisposal · 6,000
Pavankumar PSDisposal · 1,000
Chandrasekhar Reddy KandatiDisposal · 2,000
RPR Sons Advisors Pvt.Ltd. Mrs.P.Suneela Rani jointly holdingRevoke · 23,00,000
Substantial Acquisitions (SAST)

4 disclosure(s)

Market07/06/2024 · 2,00,000
Market24/11/2021 · 79,000
Inter-se Transfer / Gift30/09/2021 · 1,30,000
Inter-se Transfer / Gift30/09/2021 · 1,30,000
Company Information
Incorporated1986
ChairmanM R Kumar
AuditorDeloitte Haskins & Sells
Investor Email[email protected]; [email protected]
🌐 www.aurobindo.com ↗

📍 Plot No 2 Maitrivihar, Behind Maithri Vanam Ameerpet, Hyderabad, Telangana, 500038

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Atul Ltd.Atul Auto LimitedAU Small Finance Bank Ltd.Auri Grow India LimitedAurionpro Solutions Ltd.Auro Impex & Chemicals LimitedAurum PropTech LimitedAditya Ultra Steel Ltd.AuSom Enterprise LimitedAutomotive Axles LimitedAutoline Industries Ltd.Avadh Sugar & Energy Ltd.All “A” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search

Telegram App